1. Home
  2. Analysis
  3. Promacta
  4. Latanoprost

Promacta and Latanoprost drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Promacta (eltrombopag olamine) and Latanoprost (latanoprost). Common drug interactions include abnormal dreams among females and diarrhoea among males.

The phase IV clinical study analyzes what interactions people have when they take Promacta and Latanoprost. It is created by eHealthMe based on reports of 23 people who take the same drugs from the FDA, and is updated regularly.

What is Promacta?

Promacta has active ingredients of eltrombopag olamine. It is often used in idiopathic thrombocytopenic purpura (itp). eHealthMe is studying from 17,758 Promacta users. Check the latest studies of Promacta.

What is Latanoprost?

Latanoprost has active ingredients of latanoprost. It is often used in glaucoma. eHealthMe is studying from 33,249 Latanoprost users. Check the latest studies of Latanoprost.

On Jul, 21, 2026

23 people who take Promacta and Latanoprost together, and have interactions are studied.

Promacta and Latanoprost drug interactions.

What are the common drug interactions of Promacta and Latanoprost, by gender? *:

female:

  1. Abnormal dreams
  2. Swelling face
  3. Fatigue (feeling of tiredness)
  4. Rash
  5. Headache (pain in head)
  6. Acne (skin problems that cause pimples)
  7. Decreased appetite
  8. Drug ineffective
  9. Platelet count decreased
  10. Swelling

male:

  1. Diarrhoea
  2. Infection
  3. Pain
  4. Squamous cell carcinoma of skin (a cancer of a kind of epithelial cell, the squamous cell. these cells are the main part of the epidermis of the skin)
  5. Pneumonitis (inflammation of the walls of the alveoli in the lungs)
  6. Pyrexia (fever)
  7. Asthenia (weakness)
  8. Chronic lymphocytic leukaemia (cancer in which the bone marrow makes too many lymphocytes (a type of white blood cell))
  9. Death
  10. Fatigue (feeling of tiredness)

What are the common drug interactions of Promacta and Latanoprost, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

  1. Hypoaesthesia (reduced sense of touch or sensation)
  2. Peripheral swelling
  3. Thrombosis (formation of a blood clot inside a blood vessel)

60+:

  1. Fatigue (feeling of tiredness)
  2. Swelling face
  3. Headache (pain in head)
  4. Myalgia (muscle pain)
  5. Pain
  6. Rash
  7. Drug ineffective
  8. Platelet count decreased
  9. Swelling
  10. Asthenia (weakness)

What are the existing conditions these people have? *

  1. Pain: 5 people, 21.74%
  2. Thrombocytopenia (decrease of platelets in blood): 3 people, 13.04%
  3. Multiple Myeloma (cancer of the plasma cells): 3 people, 13.04%

* Approximation only. Some reports may have incomplete information.

Do you take Promacta and Latanoprost?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Promacta and Latanoprost:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Promacta:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Latanoprost:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Promacta and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Latanoprost and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on eltrombopag olamine and latanoprost (the active ingredients of Promacta and Latanoprost, respectively), and Promacta and Latanoprost (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.